journal article·2021-12Open access

Optical sensor arrays designed for guided manufacture of perfluorocarbon nanoemulsions with a non-synthetic stabilizer

Ryan Bardsley, Graeme Gardner, Hubert M. Tse, Christopher A. Fraker

Acta Biomaterialia· Volume 136

Abstract

Hydrophobic drugs are incorporated into oil-in-water nanoemulsions (OIW) either as new formulations or repurposed for intravenous delivery. Typically, these are manufactured through stepwise processes of sonication or high-pressure homogenization (HPH). The guiding criteria for most nanoemulsion manufacture are the size and homogeneity/polydispersity of the drug-laden particles with strict requirements for clinical injectables. To date, most formulation optimization is done through trial and error with stepwise sampling during processing utilizing dynamic light scattering (DLS), light obscuration sensing (LOS) or laser particle tracking (LPT) to assess manufacturing progress. The objective of this work was to develop and implement an in-line optical turbidity/nephelometry sensor array for the longitudinal in-process monitoring of nanoemulsion manufacture. A further objective was the use of this sensor array to rapidly optimize the manufacture of a sub-120 nm oxygen carrying perfluorocarbon nanoemulsion with a non-synthetic stabilizer. During processing, samples were taken for particle size measurement and further characterization. There was a significant correlation and agreement between particle size and sensor signal as well as improved process reproducibility through sensor-guided manufacture. Given the cost associated with nanoemulsion development and scale-up manufacture, our sensor arrays could be an invaluable tool for efficient and cost-effective drug development. Sensor-guided manufacturing was used to optimize oxygen-carrying nanoemulsions. These were tested, in vitro, for their ability to improve the viability of encapsulated endocrine clusters (mouse insulinoma, Min6) and to eliminate hypoxia due to oxygen mass transfer limitations. The nanomulsions significantly improved encapsulated cluster viability and reduced hypoxia within the microcapsule environment. STATEMENT OF SIGNIFICANCE: Nanoemulsions are rapidly becoming vehicles for the controlled release delivery of both hydrophilic and hydrophobic drugs given their large surface area for exchange. As work shifts from bench to large scale manufacturing, there is a critical need for technologies that can monitor and accumulate data during processing, particularly regarding the endpoint criteria of particle size and stability. To date, no such technology has been implemented in nanoemulsion manufacture. In this paper we develop and implement an optical sensor array for in-line nanoemulsion process monitoring and then use the array to optimize the development and manufacture of novel reproducible oxygen carrying nanoemulsions lacking synthetic surfactants.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Surface Modification and Superhydrophobicity · Advanced Sensor and Energy Harvesting Materials · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Nanoemulsions: An emerging platform for increasing the efficacy of nutraceuticals in foods10.1016/j.colsurfb.2020.111202 ↗
2. Cationic nanoemulsions with prolonged retention time as promising carriers for ophthalmic delivery of tacrolimus10.1016/j.ejps.2020.105229 ↗
3. Encapsulation and release behavior of curcumin based on nanoemulsions-filled alginate hydrogel beads10.1016/j.ijbiomac.2019.04.200 ↗
4. Polymeric micelles and nanoemulsions as drug carriers: therapeutic efficacy, toxicity, and drug resistance10.1016/j.jconrel.2015.06.019 ↗
5. Drug delivery and drug targeting with parenteral lipid nanoemulsions - A review10.1016/j.jconrel.2015.12.016 ↗
6. Stable nanoemulsions for the delivery of small molecule immune potentiators10.1016/j.xphs.2018.05.012 ↗
7. Nanoemulsions in drug delivery: formulation to medical application10.2217/nnm-2018-0088 ↗
8. Development of Theranostic perfluorocarbon nanoemulsions as a model non-opioid pain nanomedicine using a quality by design (QbD) approach10.1208/s12249-018-1287-6 ↗
9. Polymeric perfluorocarbon nanoemulsions are ultrasound-activated wireless drug infusion catheters10.1016/j.biomaterials.2019.03.021 ↗
10. Stable perfluorocarbon emulsions for the delivery of halogenated ether anesthetics10.1016/j.colsurfb.2018.09.024 ↗
11. Study on the transdermal penetration mechanism of ibuprofen nanoemulsions10.1080/03639045.2018.1546317 ↗
12. Vitamin E derivative-based multifunctional nanoemulsions for overcoming multidrug resistance in cancer10.3109/1061186X.2015.1135335 ↗
13. Synthesis of stable multifunctional perfluorocarbon nanoemulsions for cancer therapy and imaging10.1021/acs.langmuir.6b01867 ↗
14. Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's10.1016/j.lfs.2020.117394 ↗
15. Development, characterization and stability evaluation of ciprofloxacin-loaded parenteral nutrition nanoemulsions10.1080/10837450.2020.1720237 ↗
16. Ring versus straight chain perfluorocarbon emulsions for perfusion media10.1016/S0026-2862(74)80007-5 ↗
17. Perfluorocarbon emulsions in the perfusion of canine organs
18. Perfluorocarbon emulsions in cancer therapy: preliminary observations on presently available formulations10.1016/0360-3016(84)90361-4 ↗
19. Gas exchange during peritoneal perfusion with perfluorocarbon emulsions10.1007/978-1-4684-3291-6_47 ↗
20. Perfluorocarbon emulsions: one approach to intravenous artificial respiratory gas transport10.1097/00004311-199500000-00006 ↗
21. Perfluorocarbon emulsions as intravenous delivery media for hyperpolarized xenon10.1002/(SICI)1522-2594(199903)41:3<442::AID-MRM3>3.0.CO;2-7 ↗
22. Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions10.1007/s11095-010-0277-5 ↗
23. Spontaneous nucleation of stable perfluorocarbon emulsions for ultrasound contrast agents10.1021/acs.nanolett.8b03585 ↗
24. Complementary methods for the determination of dissolved oxygen content in perfluorocarbon emulsions and other solutions10.1021/jp204146n ↗
25. Optimization of perfluoro nano-scale emulsions: the importance of particle size for enhanced oxygen transfer in biomedical applications10.1016/j.colsurfb.2012.04.011 ↗
26. Rapid quantification of isoflurane in anesthetic nanoemulsions using Attenuated total reflectance fourier transform infrared spectroscopy (ATR-FTIR)10.1016/j.vibspec.2020.103095 ↗
27. Histamine release associated with intravenous delivery of a fluorocarbon-based sevoflurane emulsion in canines10.1002/jps.22488 ↗
28. Exceptionally stable fluorous emulsions for the intravenous delivery of volatile general anesthetics10.1097/ALN.0b013e3182475d4d ↗
29. Fluoropolymer-based emulsions for the intravenous delivery of sevoflurane10.1097/ALN.0b013e31818630ff ↗
30. Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers10.1097/00000539-200010000-00009 ↗
31. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers10.1097/00000539-200010000-00008 ↗
32. Use of a spectroscopic sensor to monitor droplet size distribution in emulsions using neural networks10.1002/cjce.21861 ↗
33. Albumin-derived perfluorocarbon-based artificial oxygen carriers: a physico-chemical characterization and first in vivo evaluation of biocompatibility10.1016/j.ejpb.2017.02.015 ↗
34. Functionality of albumin-derived perfluorocarbon-based artificial oxygen carriers in the Langendorff-heart (dagger)10.1080/21691401.2017.1284858 ↗
35. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles10.7150/thno.27598 ↗
36. Relighting photosensitizers by synergistic integration of albumin and perfluorocarbon for enhanced photodynamic therapy10.1021/acsami.6b14885 ↗
37. Effect of blood and microbubble oxygen and nitrogen content on perfluorocarbon-filled dextrose albumin microbubble size and efficacy: in vitro and in vivo studies10.1016/S0894-7317(98)70020-3 ↗
38. Crank · 1956
39. Quantitative assessment of islets of Langerhans encapsulated in alginate10.1089/ten.tec.2009.0510 ↗
40. A physiological pattern of oxygenation using perfluorocarbon-based culture devices maximizes pancreatic islet viability and enhances beta-cell function10.3727/096368912X657873 ↗
41. Islet oxygen consumption rate (OCR) dose predicts insulin independence in clinical islet autotransplantation10.1371/journal.pone.0134428 ↗
42. Human islet oxygen consumption rate and DNA measurements predict diabetes reversal in nude mice10.1111/j.1600-6143.2006.01655.x ↗
43. A stirred microchamber for oxygen consumption rate measurements with pancreatic islets10.1002/bit.21486 ↗
44. Influence of in vitro and in vivo oxygen modulation on beta cell differentiation from human embryonic stem cells10.5966/sctm.2013-0160 ↗
45. Enhanced oxygenation promotes beta-cell differentiation in vitro10.1634/stemcells.2007-0445 ↗
46. The Importance of proper oxygenation in 3D culture10.3389/fbioe.2021.634403 ↗
47. Aging mechanisms of perfluorocarbon emulsions using image analysis10.1016/j.jcis.2004.12.036 ↗
48. Perfluorocarbon emulsions prevent hypoxia of pancreatic beta-cells10.3727/096368911X593136 ↗
49. Perfluorocarbon distribution to liver, lung and spleen of emulsions of perfluorotributylamine (FTBA) in pigs and rats and perfluorooctyl bromide (PFOB) in rats and dogs by 19F NMR spectroscopy10.3109/10731199409138822 ↗
50. An overview of two human trials of perfluorocarbon emulsions in noncardiac surgery10.1097/SHK.0000000000000986 ↗
51. Oxygen diffusion coefficients in polymeric solutions10.1016/0009-2509(86)87040-3 ↗
52. Oxygen availability in polyethylene glycol solutions and its implications in plant-water relations10.1104/pp.55.1.20 ↗
53. Utilization of nanotechnology to improve the handling, storage and biocompatibility of bioactive lipids in food applications10.3390/foods10020365 ↗
54. Food-grade nanoemulsions: preparation, stability and application in encapsulation of bioactive compounds10.3390/molecules24234242 ↗
55. Nanoemulsions as delivery systems for lipophilic nutraceuticals: strategies for improving their formulation, stability, functionality and bioavailability10.1007/s10068-019-00731-4 ↗
56. Modeling of oxygen uptake in perfluorocarbon emulsions. Some comparisons with uptake by blood
57. Influence of perflubron emulsion particle size on blood half-life and febrile response in rats10.3109/10731199409138812 ↗